Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-21-000133
Filing Date
2021-12-06
Accepted
2021-12-06 19:17:02
Documents
1
Period of Report
2021-12-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3119
  Complete submission text file 0001765581-21-000133.txt   4645
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577
Business Address
Smith Mark Douglas (Reporting) CIK: 0001756253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 211474314